Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: A randomized double-blind clinical trial

BMC Medicine

Volumn 9, Issue , 2011, Pages

  Shab Bidar, Sakineh ^a   Neyestani, Tirang R ^b   Djazayery, Abolghassem ^a   Eshraghian, Mohammad Reza ^a   Houshiarrad, Anahita ^b   Gharavi, A'azam ^b   Kalayi, Ali ^b   Shariatzadeh, Nastaran ^b   Zahedirad, Malihe ^b   Khalaji, Niloufar ^b   Haidari, Homa ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CALCIUM; COLECALCIFEROL; CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; GELATINASE B; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL; VITAMIN D; YOGHURT;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY FAT; CREATININE URINE LEVEL; DIETARY INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; E-SELECTIN; ENDOTHELIN-1; FEMALE; FOOD, FORTIFIED; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; YOGURT;

EID: 82055171984     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-9-125     Document Type: Article

References (48)

1. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, Safaie A, Forouzanfar M, Gregg EW. Prevalence of diabetes and impaired fasting Glucose in the adult population of Iran. Diabetes Care 2008, 31:96.
2. Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol 2004, 44:397-405. 10.1177/0091270004263017, 15051748.
3. Sobel BE, Schneider DJ. Cardiovascular complications in diabetes mellitus. Curr Opin Pharmacol 2005, 5:143-148. 10.1016/j.coph.2005.01.002, 15780822.
4. Shahab A. Why does diabetes mellitus increase the risk of cardiovascular disease?. Acta Med Indones 2006, 38:33-41.
5. Meigs JB, O'Donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 2006, 55:530-537. 10.2337/diabetes.55.02.06.db05-1041, 16443791.
6. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocrine Reviews 2005, 26(5):662. 10.1210/er.2004-0002, 15798098.
7. Sarkinen BE. Vitamin D deficiency & cardiovascular disease. Nurse Pract 2011, 36:46-53.
8. Hosseinpanah F, Yarjanli M, Sheikholeslami F, Heibatollahi M, Eskandary PS, Azizi F. Associations between vitamin D and cardiovascular outcomes; Tehran Lipid and Glucose Study. Atherosclerosis 2011, 218:238-242. 10.1016/j.atherosclerosis.2011.05.016, 21676397.
9. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O, Akalin S. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009, 94:4023-4030. 10.1210/jc.2008-1212, 19584181.
10. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A, Heravifard S, Tayebinejad N, Salekzamani S, Zahedirad M. Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 2011, 93:764-771. 10.3945/ajcn.110.007336, 21289226.
11. Neyestani TR, Gharavi A, Kalayi A. Iranian diabetics may not be vitamin D deficient more than healthy subjects. Acta Med Iran 2008, 46.
12. Shab-Bidar S, Neyestani TR, Djazayery A. Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in subjects with type 2 diabetes: a study protocol for a randomized controlled clinical trial. BMC Endocr Disord 2011, 11:12. 10.1186/1472-6823-11-12, 3146888, 21696575.
13. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002, 87:144-147. 10.1210/jc.87.1.144, 11788638.
14. Neyestani TR, Gharavi A, Kalayi A. Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int J Vitam Nutr Res 2007, 77:341-346. 10.1024/0300-9831.77.5.341, 18453319.
15. Saintoge S, Bang H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial US adolescent population: the national health and nutrition examination survey (III). Pediatrics 2009, 123:797-803. 10.1542/peds.2008-1195, 19255005.
16. Ross AC, Manson JAE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology & Metabolism 2011, 96:53. 10.1210/jc.2010-2704, 22121207.
17. Neyestani TR, Gharavi A, Kalayi A. Iranian diabetics may not be vitamin D deficient more than healthy subjects. Acta Med Iran 2008, 46:337-341.
18. Nelson ML, Blum JM, Hollis BW, Rosen C, Sullivan SS. Supplements of 20 microg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80% of premenopausal women in winter. J Nutr 2009, 139:540-546. 10.3945/jn.108.096180, 19158226.
19. Hashemipour SLB, Adibi H, Javadi E, Sedaghat M, Pajouhi M, Soltani A, Shafaei AR, Hamidi Z, Khalili-Fard AR, Hossein-Nezhad A, Booya F. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 2004, 4:38-44. 10.1186/1471-2458-4-38, 517720, 15327695.
20. Bektas-Kayhan K, Unur M, Yaylim-Eraltan I, Ergen HA, Toptas B, Hafiz G, Karadeniz A, Isbir T. Association of vitamin D receptor Taq I polymorphism and susceptibility to oral squamous cell carcinoma. In Vivo 2010, 24:755-759.
21. Alimirah F, Peng X, Murillo G, Mehta RG. Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS One 2011, 6:e16024. 10.1371/journal.pone.0016024, 3025916, 21283672.
22. Pei FH, Wang YJ, Gao SL, Liu BR, Du YJ, Liu W, Yu HY, Zhao LX, Chi BR. Vitamin D receptor gene polymorphism and ulcerative colitis susceptibility in Han Chinese. J Dig Dis 2011, 12:90-98. 10.1111/j.1751-2980.2011.00483.x, 21401893.
23. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002, 51(3):356-359. 10.1053/meta.2002.29969, 11887173.
24. Mimbacas A, Trujillo J, Gascue C, Javiel G, Cardoso H. Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus. Genet Mol Res 2007, 6:534-542.
25. Mukhopadhyaya PN, Acharya A, Chavan Y, Purohit SS, Mutha A. Metagenomic study of single-nucleotide polymorphism within candidate genes associated with type 2 diabetes in an Indian population. Genet Mol Res 2010, 9:2060-2068. 10.4238/vol9-4gmr883, 20967696.
26. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, Seidell JC, Lips P. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005, 90:4119-4123. 10.1210/jc.2005-0216, 15855256.
27. Gilbert-Diamond D, Baylin A, Mora-Plazas M, Marin C, Arsenault JE, Hughes MD, Willett WC, Villamor E. Vitamin D deficiency and anthropometric indicators of adiposity in school-age children: a prospective study. Am J Clin Nutr 2010, 92:1446-1451. 10.3945/ajcn.2010.29746, 20926524.
28. Rajakumar K, de Las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA. Vitamin D Status, Adiposity, and Lipids in Black American and Caucasian Children. J Clin Endocrinol Metab 2011, 96:1560-1567. 10.1210/jc.2010-2388, 21367931.
29. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell CJ, Hoffmann U, Jacques PF, Booth SL, Vasan RS, Wolf M, Wang TJ. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010, 59:242-248. 10.2337/db09-1011, 2797928, 19833894.
30. Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, Hollenberg AN. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 2006, 281:11205-11213. 10.1074/jbc.M510343200, 16467308.
31. Wood RJ. Vitamin D and adipogenesis: new molecular insights. Nutr Rev 2008, 66:40-46. 10.1111/j.1753-4887.2007.00004.x, 18254883.
32. Holecki M, Zahorska-Markiewicz B, Wiecek A, Mizia-Stec K, Nieszporek T, Zak-Golab A. Influence of calcium and vitamin D supplementation on weight and fat loss in obese women. Obes Facts 2008, 1:274-279.
33. Reinehr T, de Sousa G, Alexy U, Kersting M, Andler W. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007, 157:225-232. 10.1530/EJE-07-0188, 17656603.
34. Hall LM, Kimlin MG, Aronov PA, Hammock BD, Slusser JR, Woodhouse LR, Stephensen CB. Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr 2010, 140:542-550. 10.3945/jn.109.115253, 2821886, 20053937.
35. Pilz S, Tomaschitz A. Role of vitamin D in arterial hypertension. Expert Rev Cardiovasc Ther 2010, 8:1599-1608. 10.1586/erc.10.142, 21090935.
36. Daly RM, Nowson CA. Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men. Eur J Clin Nutr 2009, 63:993-1000. 10.1038/ejcn.2008.79, 19156159.
37. Major GC, Alarie F, Dore J, Phouttama S, Tremblay A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007, 85:54-59.
38. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005, 109:143-159.
39. Death AK, Fisher EJ, McGrath KC, Yue DK. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003, 168:263-269. 10.1016/S0021-9150(03)00140-0, 12801609.
40. Mulder H. Matrix metalloproteinases: keys to healthier blood vessels in diabetes?. J Endocrinol 2011, 210:1-2. 10.1530/JOE-11-0168, 21555344.
41. Natarajan A, Marshall SM, Kesteven P, McComb JM, Rutter MK. Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetes(1). Diabet Med 2011, 28:1201-1205. 10.1111/j.1464-5491.2011.03311.x, 21480978.
42. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011, 57:63-69. 10.1161/HYPERTENSIONAHA.110.160929, 21115878.
43. Yiu YF, Chan YH, Yiu KH, Siu CW, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Cheung BM, Tse HF. Vitamin D Deficiency Is Associated with Depletion of Circulating Endothelial Progenitor Cells and Endothelial Dysfunction in Patients with Type 2 Diabetes. J Clin Endocrinol Metab 2011, 96:E830-835. 10.1210/jc.2010-2212, 21325459.
44. Jung KH, Chu K, Lee ST, Bahn JJ, Kim JH, Kim M, Lee SK, Roh JK. Risk of macrovascular complications in type 2 diabetes mellitus: endothelial microparticle profiles. Cerebrovasc Dis 2011, 31:485-493. 10.1159/000324383, 21411989.
45. Tousoulis D, Koniari K, Antoniades C, Miliou A, Noutsou M, Nikolopoulou A, Papageorgiou N, Marinou K, Stefanadi E, Stefanadis C. Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study. Clin Ther 2010, 32:1720-1728. 10.1016/j.clinthera.2010.09.007, 21194594.
46. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008, 25:320-325. 10.1111/j.1464-5491.2007.02360.x, 18279409.
47. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-court D, Aganna E, Price CP, Boucher BJ. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?. QJM 2002, 95:787-796. 10.1093/qjmed/95.12.787, 12454321.
48. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007, 18:613-620. 10.1681/ASN.2006060573, 17202417.